







Stroke is a common disorder with profound lasting e!ects and the UK’s fourth 
leading cause of morbidity. One important a"er-e!ect is post-stroke depression 
(PSD). PSD can impact overall recovery, however treatment guidelines remain 
unclear. Usual care generally consists of antidepressants despite cognitive behavioural 
therapy (CBT) being a #rst-line treatment for depression. This evidence review aims 
to assess the e!ectiveness of CBT compared with antidepressants for treating PSD in 
adult stroke patients. Evidence searches of MEDLINE, PUBMED, The Cochrane 
Library, PsycINFO and NICE Evidence Search were conducted using strict search 
terms. The results were screened and appraised. A reference list search was carried out 
and included reviews with these results also screened and appraised. Appraisals used 
the AGREE II tool for guidelines and the CASP systematic review and randomised 
controlled trial (RCT) frameworks. Each stage was carried out by two independent 
reviewers, with disagreements resolved by a third reviewer. A"er applying inclusion 
and exclusion criteria, two guidelines, four reviews and one RCT were included in 
the synthesis. One review found CBT e!ective for treating PSD. Two reviews found 
CBT combined with antidepressants more e!ective than antidepressants alone. One 
review concluded CBT was ine!ective for treating PSD. A single RCT found CBT 
more e!ective than antidepressants if PSD onset was nine months post-stroke, but 
PSD onset six months post-stroke was most e!ectively treated by antidepressants. 
Results for less than six months post-stroke were inconclusive.  In conclusion, the 
#ndings of this evidence review suggest it is not possible to de#nitively conclude 
whether CBT is more or less e!ective than antidepressants. A combination of both is 
likely to be most e!ective. Lack of research means conclusions for clinical practice are 
di$cult to draw. More research is needed before speci#c guidelines can be compiled. 
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The World Health Organisation (WHO) de#nes stroke as a clinical 
syndrome characterised by “rapidly developing clinical signs of focal 
or global disturbance of cerebral function, lasting more than 24 
hours or leading to death, with no apparent cause apart from that 
of vascular origin”. (1) Stroke is the fourth leading cause of death 
in the UK. (2) The long-term burden of stroke on survivors is just 
as signi#cant: in 2016, stroke accounted for close to 20,000 age-
speci#c years with lived disability per 100,000 in England. (3)
It is well-acknowledged that stroke can result in functional and 
physical decline. (4) Advances in the multidisciplinary team (MDT) 
approach to stroke a"ercare, particularly physiotherapy, go some 
way towards addressing this issue. (5) However, the psychological 
e!ects of stroke, despite being seen in 30% of stroke patients, do 
not have such a recognised approach. (6) 
An example of this is post-stroke depression (PSD). PSD can 
occur immediately or even years a"er a stroke and can be more 
debilitating for patients than the physical e!ects of stroke. (7) 
Additionally, PSD has the potential to seriously impede physical 
recovery due to its impact on motivation. (7)
The mechanism of PSD development is currently unclear, but it 
appears to be a combination of the direct physical e!ects of stroke 
on the brain and a psychological reaction to sudden and marked 
functional decline. (8) This ambiguity may account for the lack of 
recognised interventions for PSD, with the National Institute for 
Health and Care Excellence (NICE) stroke guidelines suggesting no 
clear pathway, stating instead to “Manage depression or anxiety in 
people a"er stroke who have no cognitive impairment in line with 
recommendations in depression in adults with a chronic physical 
health problem”. (9)
In practice, lack of psychological practitioners within the stroke 
MDT o"en means specialised psychological treatment is not 
available, and the condition is poorly managed in the inpatient 
setting. (10)
Stroke patients still su!ering from PSD a"er discharge are 
sometimes able to access general psychological support and 
cognitive behavioural therapy (CBT) through their general 
practitioner. CBT is the #rst-line treatment for depression in adults 
(11) and it is therefore thought that it may have some merit in 
treating PSD. 
Evidently, PSD is an area in stroke rehabilitation which is 
underfunded and poorly understood. (8) There is limited 
knowledge into the best way to manage this condition, whether 
antidepressants, CBT, or a combination is most e!ective. The 
positive consequences for post-stroke patients of developing a clear 
and e!ective strategy for treating PSD could be extensive in both 
physical and psychological recovery.
Therefore, the aim of this evidence review is to assess the 
e!ectiveness of CBT compared with antidepressants for the 
treatment of PSD in adult stroke patients. 
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Review Question
A population, intervention, comparator and outcome (PICO) 
framework was generated. This formed the basis of the review 
question: What is the e!ectiveness of cognitive behavioural therapy 
compared with antidepressants for the treatment of post-stroke 
depression in adult stroke patients? 
The PICO framework was as follows:
Population: Adults who have had a stroke (according to the WHO 
de#nition) (1) and su!er from post-stroke depression, de#ned as 
depressive disorder due to another medical condition (i.e., stroke) 
(4, 12)
Intervention: CBT, de#ned as talking therapy to help change a 
patient’s thinking and behaviour (13)
Comparator: Antidepressants
Outcome: Primary Outcome: Amelioration in depression (assessed 
by any validated depression rating scale)
Secondary Outcomes: Improvement in quality of life, improved 
functional ability
Literature Searches
A thorough literature search for guidelines, reviews and primary 
research studies was subsequently undertaken. Each of the steps 
outlined below were carried out by two independent reviewers with 
any disagreements resolved by a third reviewer. 
Guidelines were searched for using NICE Evidence Search (Figure 
1). Broad search terms (Table 1) were used because a scoping 
search revealed limited guidance on PSD. The search strategy 
is summarised in Figure 1. First, title/summary screening was 
undertaken, followed by a screen of full texts. Those meeting the 
inclusion criteria (Table 2) were then appraised using the AGREE 
II tool. (14) 
Next, a review search was conducted using speci#c search terms 
(Table 1) using the following databases: MEDLINE, PUBMED, 
the Cochrane Library, and PsycINFO. Scoping searches revealed 
that including the search term ‘antidepressant’ would detrimentally 
limit the results as some papers used speci#c antidepressant names. 
It was therefore decided that to capture all relevant research, the use 
of antidepressants would form part of the inclusion criteria, instead 
of search terminology. More #lters were added when searching 
PUBMED, such as ‘meta-analysis’ in addition to ‘review’, as the 
database uses #lters and not limits. The search strategy used is 
demonstrated in Figure 2. Identi#ed reviews were collated and 
duplicates were removed. Titles and abstracts were then screened to 
ensure the papers met inclusion and exclusion criteria. Next, a full 
text screen was undertaken. A reference list search was carried out 
on all included reviews. The Critical Appraisal Skills Programme 
(CASP) checklist for systematic reviews was used to critically 







Finally, a search for primary research studies was completed using 
speci#c search terms (Table 1). The search was carried out on the 
following databases: MEDLINE, PUBMED, the Cochrane Library, 
and PsycINFO. A similar search strategy to the review search was 
carried out (Figure 2), with suitable papers being critically appraised 
using the CASP checklist for randomised controlled trials (RCTs). 
(16) One relevant RCT was identi#ed through the search. (17) 
Despite being appraised in an included meta-analysis, (18) this 
study was re-evaluated by the current authors and is included in 
the results section below as it was the only paper to make a direct 
comparison between CBT alone and antidepressants alone, thus 
addressing the central review question. 
Search Terms
Evidence searches on the databases listed above were carried out 
with the search terms and limits summarised in Table 1. The British 
English spellings of search terms were used, except for MeSH terms 
as the databases used the American English spelling. All PUBMED 
MeSH terms were automatically searched as both MeSH terms and 
keywords. See Appendix 1 for speci#c search terms used and results 
from each database. 
Inclusion and Exclusion Criteria
The inclusion criteria applied to the guideline search were: English 
language guidelines, guidelines relevant to clinical practice, and 
guidelines that include recommendations for the treatment of PSD.
The inclusion criteria applied to the searches for reviews and 
primary research studies were: studies including patients who meet 
the review de#nition of stroke and the review de#nition of PSD, 
studies which evaluate CBT (according to this review’s de#nition), 
and studies including an antidepressant comparator.
The exclusion criteria applied to the searches for reviews and 




The search identi#ed 2 guidelines, (19, 20) 3 narrative reviews, 
(21-23) 1 meta-analysis (18) and 1 RCT (17) meeting the inclusion 
criteria (see Figures 1 and 2). A reference list search returned 
no new papers. The results of identi#ed papers are summarised 
in Table 2. Sample sizes were available for two out of the seven 
included literatures and were as follows: Wang et al (23 studies, 
1972 participants), (18) Gao et al (2113 participants). (17)
Guidelines
There were no NICE guidelines identi#ed. Two guideline 
documents were appraised using the AGREE-Il tool: (14) the 
American Heart Association guidelines (19) for PSD and the 
Scottish Intercollegiate Guidelines Network (SIGN) (20) for stroke 
management.
The American Heart Association guidelines (19) stated that seven 
trials, (24-28) which investigated 775 individuals with PSD, 
suggested that “brief psychosocial interventions” may be useful in 
treating PSD. These seven trials were published in #ve research 
papers. (24-28) However, the guidelines did not comment on 
the concurrent use of antidepressants and there were few details 
about appraisal. Limitations recognised by the authors included 
small sample sizes and single-centre recruitment, so the trials were 
unlikely to be representative of a wider population. Due to the 
similar pattern of results demonstrated by the included studies, the 
authors concluded that psychosocial interventions show promise, 
but did not make any concrete recommendations.
The SIGN guideline published in 2010, (20) which addresses 
the management of patients a"er a stroke, stated that patients 
should be given antidepressants to treat their PSD. However, if the 
antidepressants did not work, the guidelines advised that patients 
should be considered for a talking-based therapy such as CBT. The 
SIGN guidelines relied on a Cochrane review of antidepressant 
and psychotherapy treatment for PSD to support their #ndings, 
(29) however, the studies included in this review had a high level of 
heterogeneity and the study types were not stated. As there was very 
little robust evidence of whether psychological therapies (including 
CBT) have e$cacy in PSD treatment, the guidelines struggled to 
determine its usefulness. 
Meta-analysis
One meta-analysis, Wang et al (18) was identi#ed and appraised. 
A meta-analysis containing RCTs is the best available evidence 
according to the hierarchy of evidence; (30) therefore, this paper 
was appraised using the CASP systematic review checklist. (15)
Wang et al evaluated whether CBT was more e!ective than 
standard care (seven RCTs), or whether CBT combined with an 
antidepressant was more e!ective than the antidepressant alone (14 
RCTs) in treating PSD. (18) The results of the review demonstrated 
that both CBT alone and CBT combined with antidepressants were 
signi#cantly more e!ective at reducing PSD than in the control 
groups (placebo, or antidepressant without CBT). 
However, two other RCTs in this review had subjects in both the 
intervention (CBT) and control (placebo) groups who received 
antidepressants. There was no signi#cant di!erence between 
the intervention and control groups, however these results may 
be swayed by some participants using antidepressants in the 
intervention/control groups. It would have been useful to see a 
baseline characteristics table to assess whether this would have had 
an e!ect. These results are shown in Table 3.
CBT was also shown to have a positive impact on anxiety, activities 
of daily living and neurological functional de#cient as secondary 
outcomes. 
Wang et al had a clearly de#ned PICO (P = patients with 




Table 1  
Search terms used to generate search results for guidelines, systematic reviews and primary research studies
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Search Database Search Terms (MeSH terms underlined, keywords = normal type)
Limits/Filters 
Applied
Guidelines NICE Evidence Search Post-stroke Depression Guidance
Reviews MEDLINE
(1946 – current day)
(Stroke OR Brain Ischaemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular Accident) 
AND
(Depression OR Post-stroke depression) AND
(Cognitive Behavioural Therapy or Counseling or 




PUBMED (Stroke OR Brain Ischaemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular Accident) 
AND 
(Depression OR Post-stroke depression) AND 
(Cognitive Behavioural Therapy OR Counseling OR 






Cochrane Library (Stroke OR Brain Ischaemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular Accident) 
AND 
(Depression OR Post-stroke depression) AND 
(Cognitive Behavioural Therapy OR Counseling OR 




(1967 – current day)
(Stroke OR Brain Ischaemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular 
Accidents) AND 
(Depression OR Post-stroke depression) AND 
(Cognitive Behavioural Therapy OR Counseling OR 









(1946 – current day) 
(Stroke OR Brain Ischemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular Accident) 
AND
(Depression OR Post-stroke depression) AND
(Cognitive Behavioral Therapy or Counseling or 





PUBMED (Stroke OR Brain Ischaemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular Accident) 
AND 
(Depression OR Post-stroke depression) AND 
(Cognitive Behavioural Therapy OR Counseling OR 





Cochrane library (Stroke OR Brain Ischaemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular Accident) 
AND 
(Depression OR Post-stroke depression) AND 
(Cognitive Behavioural Therapy OR Counseling OR 




(1967 – current day)
(Stroke OR Brain Ischaemia OR Cerebral Haemorrhage
OR Cerebrovascular Event OR Cerebrovascular 
Accidents) AND 
(Depression OR Post-stroke depression) AND 
(Cognitive Behavioural Therapy OR Counseling OR 






Flowchart demonstrating the search 
strategy for guidelines
Flowchart includes the number of 
guidelines included and excluded at each 
Figure 2 
Flowchart demonstrating the search 
strategy for reviews and primary research
Flowchart includes the number of 
primary research studies and reviews 
included and excluded at each stage. 
Abbreviations: n = number of articles, 








Summary of Results of Included Literature
Table 3 






antidepressants, C = placebo or the same antidepressant as with 
the CBT group, O = e$cacy) and comprehensive search strategy 
including English and Chinese databases. (18) The search was 
carried out by three independent investigators. The inclusion of 
non-English language papers from the Chinese databases reduces 
the risk of publication bias, as demonstrated by the Egger’s 
regression test that found no statistically signi#cant evidence of 
publication bias for the overall e!ect of CBT on PSD. 
The search identi#ed 23 applicable RCTs, which were then divided 
into the three subgroups shown in Table 3. They included a total 
sample size of 1,972 participants, with 21 of the studies (sample size 
1,829) carried out on a Chinese population.
The quality of the studies was assessed using both the Cochrane 
Risk of Bias Tool and the Jadad scale. A study with a Jadad score of 
3 or more was said to be of high quality; less than 3 indicated low 
quality. Only nine of the studies were found to be of high quality 
according to this scale. Reasons for the low quality of studies were 
secondary to the methods of randomisation being unclear in 15 
studies, and poor reporting of compliance rates for the intervention. 
The authors also used I2 statistics to measure heterogeneity, with 
an I2 of 82% indicating signi#cant heterogeneity between the 
studies. Although the results were statistically signi#cant, the 
heterogeneity could mean that it was inappropriate to combine the 
di!erent studies’ results, as the di!erent studies used varied methods 
and sample sizes. This was a common theme in the literature found.
Narrative Reviews
Kneebone et al, (21) Robinson et al, (22) and Hadidi et al 
(23) carried out literature reviews to collate information on 
psychological interventions in PSD. Most of the research included 
in these papers were RCTs, the highest quality primary research 
for interventions, according to the hierarchy of evidence. (21, 30) 
Despite RCTs being included, meta-analysis was not possible, due 
to the heterogeneity of the studies. For example, many di!erent 
types of psychological interventions were assessed in each review, 
such as ecosystem-focussed therapy or problem-solving therapy. 
Therefore, despite these reviews containing high-quality primary 
research, the Wang et al meta-analysis is the highest quality 
evidence included in this evidence review. (18, 30)
Kneebone et al concluded that although CBT represented a 
promising area of future research, more investigations and high-
quality RCTs were needed to fully establish its e!ect on PSD. 
(21) More recent reviews from Robinson et al and Hadidi et al 
concluded that CBT alone was ine!ective. (22, 23) However, 
Hadidi et al found that a combination of problem-solving therapy 
(falling under this review’s de#nition of CBT) and antidepressants 
was more likely to be e!ective than antidepressants alone. (23)
These three reviews did not have speci#c PICO frameworks or 
focused questions, (21-23) but they all had clear aims: to gather all 
relevant information on psychological interventions (Kneebone 
et al) (21) and “nonpharmacological interventions” (Hadidi et al). 
(23) The purpose of the Robinson et al paper was to investigate 
antidepressants. (22) However due to their non-speci#c search 
terms, including “post stroke depression AND trial”, (22) it 
also included studies on psychological interventions, which were 
discussed by the authors, hence its inclusion in this review.
All reviews searched medical databases such as MEDLINE 
and psychology databases such as PsycINFO. They carried out 
reference searches and Hadidi et al reported their appropriate 
inclusion and exclusion criteria, for example, qualitative studies 
were excluded, and the patients included were required to have 
depressive symptoms. (23. However, there was no universal scale 
used by Hadidi et al to assess these symptoms. (23)
All three reviews included papers relevant to their aim. Kneebone 
et al included case studies and uncontrolled trials, (21) making it 
more likely that results could have been a!ected by confounders 
and bias, such as selection bias. The inclusion of such studies was 
recognised as a limitation by the authors. However, as this review 
was published in 2000 when there was less information available 
regarding the mental health of stroke survivors, these preliminary 
papers provide a useful introduction to this topic. 
None of the reviews demonstrated a consistent appraisal of the 
quality of papers included, and full information on some of the 
studies, such as setting and the demographics of the population, was 
not available, therefore it was di$cult to fully assess the quality of 
the paper. 
The quality of case studies on CBT, featured in Kneebone et al. 
(21) were not evaluated and it was simply stated they resulted in 
an improvement in mood. The authors assessed the quality of 
the uncontrolled studies and concluded they were poor quality 
preliminary studies due to the lack of a control group. The quality 
of the few RCTs included was not formally assessed, there was 
no detail of randomisation or blinding given and most had small 
sample sizes. The RCT results showed that CBT or other forms 
of psychotherapy were not e!ective or demonstrated “borderline 
statistical signi#cance”, (21) however the authors emphasised the 
poor quality of these papers and therefore concluded that more 
RCTs were needed.
Incomplete details were given on the RCTs featured in Robinson et 
al. (22) but it was made clear that RCTs evaluating problem-solving 
therapy had small sample sizes and high dropout rates, increasing 
the chance of confounding factors and attrition bias a!ecting 
results. It was not stated if intention-to-treat analysis was used. 
Out of these three reviews, Hadidi et al. had considered most 
thoroughly the quality of papers included. (23) Although there was 
limited information about how this was carried out, the authors 
did discuss how the rigour of the studies varied, considering sample 
size (ranging from 14-411), time a"er stroke (48 hours to 5 years) 
and di!erences in baseline characteristics (for example variation in 
depression scores between groups). Hadidi et al., (23) similarly to 
the other reviews, did not present results as a meta-analysis. This 
was not justi#ed by the authors, but as mentioned previously, was 
likely due to the heterogeneity between studies. Only one RCT 
explicitly stating CBT as the intervention was included. (31) The 
authors recognised the limitations of using this study, for example 
the CBT practitioner was not fully trained, and possible cognitive 





Considering all three narrative reviews, it is di$cult to evaluate 
whether the results are applicable to the local population, due 
to the poor quality and lack of information on the participant 
characteristics. All three reviews concluded that CBT is a promising 
area of research.
Primary Study (RCT)
One primary study, an RCT by Gao et al., (17) was found and 
appraised using the CASP RCT checklist. (16) As stated previously, 
this is the only relevant RCT that was found in the literature search 
that directly compared CBT alone to antidepressants alone, thus 
making it the most suitable study found for the review question. 
For this reason, it was covered in this review despite already being 
included in the Wang et al. meta-analysis (18). RCTs are not 
considered as robust as “#ltered information” (30) such as meta-
analyses and guidelines, therefore it is important to re%ect on these 
results in combination with the literature appraised above. Gao et 
al. examined the e!ectiveness of CBT treatment strati#ed by time 
taken for PSD to develop a"er stroke. (17) This was not quanti#ed 
in the Wang et al. meta-analysis. (18)
Gao et al. took patient groups at discharge and at 3, 6 and 9 months 
post-discharge following a stroke, and then split these groups 
into A, B and C as follows: Group A had placebo tablets and 
placebo psychological intervention, Group B had active citalopram 
antidepressant tablets and placebo psychological intervention, and 
Group C had placebo tablets and active CBT. (17)
It was a single-blind trial - the patients were blinded to the 
treatment they were receiving. They then followed these patients 
up for 3 months and used the Hamilton Depression Rating Scale 
(HAM-D) and the Bech-Rafaelsen Melancholia Scale (MES) to 
measure depressive symptoms.
The results of the study, when time strati#cation was not 
considered, showed no signi#cant di!erences in the HAM-D 
scores between groups A, B and C. The only signi#cant di!erence 
in MES scores was a lower score (fewer depressive symptoms) 
in Group B compared to Group A (p=0.02). This suggests 
antidepressants could be more e!ective than placebo tablets, 
whereas CBT is not signi#cantly di!erent to placebo psychological 
intervention at reducing depressive symptoms. These results 
contrast with Wang et al., (18) which showed that CBT alone 
was signi#cantly more e!ective compared to placebo. It could be 
said that the results from Wang et al. are more valid as systematic 
reviews are higher in the hierarchy of evidence than RCTs. (18, 
30) Furthermore, Gao et al. was not signi#cantly highly weighted 
within the meta-analysis. (17, 18) However, Gao et al. was only 
one of two studies included in the meta-analysis with the highest 
possible Jadad score of 5, (17) and therefore is deemed to be of 
higher quality than the other RCTs in Wang et al. (18). This could 
mean that the meta-analysis results may be produced from RCTs 
with a higher risk of bias, and the Gao et al. results are more likely 
to be reliable. 
Importantly for this review question, Gao et al. demonstrated that, 
without strati#cation by time, there was no signi#cant di!erence 
in the depression rating scores between the groups receiving CBT 
alone (Group C) and the antidepressant alone (Group B). (17)
However, when time strati#cation was considered, there was a 
di!erent picture of results. At 6 months post-discharge, Group B 
had signi#cantly lower HAM-D/MES scores when compared to 
Group A, and Group C showed no signi#cant decrease in score in 
comparison to Group A. This could suggest that antidepressants 
(Group B) are more e!ective at reducing depressive symptoms 
than CBT (Group C) when treatment is initiated 6 months post-
discharge. Furthermore, at 9 months post-discharge, Group C 
showed signi#cantly lower MES scores compared to Group A, and 
Group B showed no signi#cant decrease in comparison to Group 
A. These results demonstrate that CBT (Group C) may be more 
e!ective than antidepressants (Group B) when these symptoms 
develop later, when CBT treatment is initiated at 9 months post-
discharge.
Gao et al. had a clearly focused PICO, appropriate randomisation 
with all groups having similar baseline characteristics and detailed 
follow-up of patients and drop-outs, with reasons provided. (17) 
However, some limitations included that there was no mention 
of whether participants were analysed with an intention-to-treat 
analysis. If not, this could lead to attrition bias and selection 
bias, due to loss of randomisation. Also, sample sizes were small, 
especially when split into time-strati#ed groups, therefore reducing 
the power of detecting signi#cant di!erences between the 
subgroups.
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The aim of this review was to assess the e!ectiveness of CBT 
compared to the e!ectiveness of antidepressants for the treatment 
of adults with PSD. The main #ndings suggest a mixture of results 
regarding the e!ectiveness of CBT, however there is evidence 
that this therapy could have a larger role in PSD treatment than 
it currently does. The available evidence varies considerably in 
methodological quality and so further research into the treatment 
for PSD is needed. 
It should be considered that one of the reasons for lack of research 
into the treatment of PSD is a lack of understanding of the 
development of PSD. (8) The question remains over whether 
PSD results from the direct physical e!ects of stroke on the brain, 
a psychological reaction to the patient’s own sudden and marked 
functional decline, or, perhaps more likely, a combination of 
both causes. Should this important question be answered, our 
understanding of PSD will improve and therefore this may lead 
to more research into PSD treatment. For example, it is not yet 
understood why CBT appears to be more e!ective in some studies 
than antidepressants. A theory for this could be that the possible 
biological mechanism of PSD does not align with the mechanism 
of action of antidepressants. However, we will not know if this is 
the case until future research on the development of PSD becomes 
available. 




Furthermore, changes in methodology could address challenges 
in conducting RCTs in this population group. Patients struggling 
with the most severe e!ects of stroke and post-stroke depression 
may be less likely to consent to participating in a study. The 
potential participation bias resulting from this could be reduced 
in future studies by controlling for severity of stroke and expected 
rehabilitation time. Attrition rates in those most a!ected by their 
stroke may also be higher and this is something to explore in the 
future, to ensure validity of results. In terms of impact on current 
practice, despite this review #nding that there is not enough 
evidence for making de#nitive clinical guidelines, it should allow 
clinicians to feel more con#dent in suggesting CBT as a treatment 
option for PSD if they feel it is right for their patient. This may 
encourage more doctor-patient discussion and allow patients to be 
more involved in treatment decisions. 
Beyond the boundaries of this review lies the question of how 
the availability, cost and patient acceptability of antidepressants 
and CBT in%uence a clinician’s treatment decision, consequently 
a!ecting a patient’s overall functional recovery from PSD. This 
in%uence on recovery has implications on the #nancial aspect 
of managing PSD. Improvements in both the psychological and 
physical e!ects of PSD are likely to decrease burden of care, which 
is usually high in post-stroke patients, allowing NHS resources to 
be used more e$ciently. 
&"
To conclude, the treatment of PSD is an important yet under-
funded area of research despite being a common consequence 
of a stroke. The #ndings of this review suggest the evidence 
supporting the use of CBT versus antidepressants for the 
treatment of PSD is inconclusive, which may in part be due to 
low levels of methodological quality. In practice, a combination of 
pharmacological and CBT treatment is likely to be most e!ective 
and this warrants further research. Future high-quality RCTs that 
include culturally diverse patient populations and clinically relevant 
interventions, comparisons and outcomes are needed to address this 
research question.
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Furthermore, considering evidence around treating depression 
thought to be a consequence of other chronic illnesses may enable 
us to identify further treatment options to explore. 
However, the possible direct biological mechanism of PSD means 
that a direct comparison to depression in other chronic illnesses may 
be unhelpful. This further emphasises the need for research into 
PSD development. 
It has been identi#ed that if a patient was to be given CBT as a PSD 
treatment, then this CBT should be individually adapted to suit 
di!erent patient needs. (8) This is because PSD a!ects individuals 
di!erently such as e!ects on motivation and sleep, and a universal 
CBT protocol would not consider these di!erences. Qualitative 
research could help to understand the impact these aspects have on 
patients as individuals, where current scoring systems may fail to 
grasp the range of emotions patients feel in such a hard time. 
This review has highlighted that there are prominent gaps in the 
research of treating PSD. One possible reason for this lack research 
could be societal attitudes towards mental ill-health. As mental 
illness is not de#ned by physical attributes, it is said that society in 
general #nds it harder to accept that mental health is as important as 
physical health. (32) A 2011 NHS report about attitudes to mental 
illness found that 23% of the participants did not agree that mental 
illness was akin to physical illness. (32) These beliefs are re%ected in 
funding di!erences between physical and mental illness. (33) This 
could explain the lack of research on the topic of PSD treatment, 
particular in the context of the sometimes-life-changing physical 
di$culties stroke can cause. 
To address gaps in the knowledge of PSD, future RCTs should be 
conducted with a culturally diverse study population, mirroring that 
of the UK. This is of particular importance because most current 
evidence on this topic area was conducted on mainly Chinese 
populations. (17, 18) CBT as a treatment focuses on innate beliefs 
meaning participants from di!erent cultures with di!erent attitudes 
towards mental health are likely to respond di!erently to it. Hence 
it may not be appropriate for such studies to form the basis of UK 
national treatment guidelines. Understanding the issue within the 
context of the UK population to form relevant guidelines could 
provide public health bene#t, given that the disability burden post-
stroke is so high in the UK. 
Changes in the methodology of current studies could help 
produce results more applicable to medical practice. High-quality 
RCTs directly comparing antidepressants to individually tailored 
CBT would be particularly useful for compiling new NICE 
guidelines. Continuing to research the e!ect of treatments started 
at di!erent time periods post-stroke would be more re%ective of 
clinical practice as patients are likely to present with depression at 
various times a"er their stroke. The emergence of such research 
would allow future clinicians to fully evaluate whether CBT is a 
worthwhile and possibly more e!ective treatment for PSD than 
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